Free. Unsubscribe any time.
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 37 transactions and 124,277 shares. None carries the SEC's AFF10B5ONE flag; all 19 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-07-01, came 5 days after the one before it (2026-06-26) and reports 1 transaction against 2 in the filing before it.
- The sales it reports total 7,400 shares, 3,756 fewer than the 11,156 in the filing before it.
- Its 19 filings on file run from 2025-10-01 to 2026-07-01, and state 3 plan adoption dates, from 2025-05-09 to 2025-09-25.
Trades in Cadrenal Therapeutics, Inc. 37
- Pham Quang X — 2025-09-29 · S · 419 shares
- Szot Matthew K — 2025-09-29 · S · 100 shares
- Pham Quang X — 2025-10-01 · S · 881 shares
- Szot Matthew K — 2025-10-01 · S · 1,700 shares
- Pham Quang X — 2025-10-02 · S · 500 shares
- Szot Matthew K — 2025-10-06 · S · 107 shares
- Pham Quang X — 2025-10-09 · S · 1,800 shares
- Szot Matthew K — 2025-10-09 · S · 1,693 shares
- Pham Quang X — 2025-10-13 · S · 1,800 shares
- Szot Matthew K — 2025-10-13 · S · 1,800 shares
- Pham Quang X — 2025-10-24 · S · 1,129 shares
- Szot Matthew K — 2025-10-24 · S · 1,800 shares
Adoption dates in Cadrenal Therapeutics, Inc. 3
- 2025-05-09 — stated in 2 filings
- 2025-09-18 — stated in 1 filing
- 2025-09-25 — stated in 10 filings
Results prints in Cadrenal Therapeutics, Inc. 0
Trades before a print in Cadrenal Therapeutics, Inc. 0
Interval to Cadrenal Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 37no later print
Adoption dates Cadrenal Therapeutics, Inc. states
- 2025-05-09 in 2 filings
- 2025-09-18 in 1 filing
- 2025-09-25 in 10 filings
Filing text: “10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025”
Sources: SEC EDGAR full-text search and the SEC submissions API.